The Analytical Cytometry Shared Resource (ACSR) is a 400 square foot state-of-the-art facility located in the Comprehensive Cancer Center that is at the center of the University Medical Center complex. The P2 laboratory that holds the cytometry equipment used by CCC members is equipped with a biohazard cell culture hood, centrifuge, water baths, and a fluorescent microscope. The instrumentation within the Shared Resource includes two Coulter EPICS Elite flow cytometer/cell sorters. One of the Elite cell sorters is equipped with a 5 W argon water-cooled laser, a 15 mW air-cooled argon laser and an air-cooled helium-neon laser with upgrades including a 5th photomultiplier tube and a gated amplifier, which provides the capability of performing up to 5 color multiparameter analysis of biological particles. In addition, this instrument has a high- speed """"""""ESP"""""""" sort module upgrade which allows high speed sterile sorting of large quantities of cells with high purity and recovery. This instrument can also be used with a modular 96-well format """"""""autoclone"""""""" device that can be used to clone and culture single cells from heterogeneous populations. The other Elite cell sorter is equipped with an air-cooled argon laser and a helium-neon laser that is used for analysis of up to 4 parameters and for cell sorting. The facility has recently acquired a Coulter XL-MCL, which is an automated flow cytometer that provides rapid analytical capabilities with more efficient use of technical support. CCC members using the ACSR have access to on-line and off-line computer analysis capabilities, including multiple software programs for analysis of such types of data as DNA content, the presence and abundance of cell cycle proteins, cell populations, undergoing apoptosis, and identification of subpopulations of peripheral blood leukocytes using multiple antibody markers. In addition to the analytical cytometry/cell sorter instrumentation, this laboratory includes a computer-based image analysis system and an off-line computer workstation. Fredika Robertson, Ph.D., is Director of the CC Analytical Cytometry Shared Resource, Andrew Oberysyzn, M.S., is the Senior Research Associate and Key Operator of the cell sorters and Jaime Miracle is the Research Assistant who provides technical support for the automated analyzer. These individuals provide consultation to CCC members for flow cytometry/cell sorting, develop protocols, and provide assistance with data analysis, meeting presentations, and publication quality flow cytometry graphics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-26
Application #
6430838
Study Section
Project Start
2001-03-07
Project End
2001-11-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Lai, Xiulan; Stiff, Andrew; Duggan, Megan et al. (2018) Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors. Proc Natl Acad Sci U S A 115:5534-5539
Rolfo, Christian; Mack, Philip C; Scagliotti, Giorgio V et al. (2018) Liquid Biopsy for Advanced Non-Small Cell LungĀ Cancer (NSCLC): A Statement Paper from theĀ IASLC. J Thorac Oncol 13:1248-1268
Ren, Yulin; Gallucci, Judith C; Li, Xinxin et al. (2018) Crystal Structures and Human Leukemia Cell Apoptosis Inducible Activities of Parthenolide Analogues Isolated from Piptocoma rufescens. J Nat Prod 81:554-561
McDonald, J Tyson; Kritharis, Athena; Beheshti, Afshin et al. (2018) Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel. Oncotarget 9:22693-22702
Nguyen, Phuong; Wuthrick, Evan; Chablani, Priyanka et al. (2018) Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience. Am J Clin Oncol 41:140-146
Elchuri, Sailaja V; Rajasekaran, Swetha; Miles, Wayne O (2018) RNA-Sequencing of Primary Retinoblastoma Tumors Provides New Insights and Challenges Into Tumor Development. Front Genet 9:170
Reiff, Sean D; Muhowski, Elizabeth M; Guinn, Daphne et al. (2018) Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL. Blood 132:1039-1049
Nabar, Gauri M; Mahajan, Kalpesh D; Calhoun, Mark A et al. (2018) Micelle-templated, poly(lactic-co-glycolic acid) nanoparticles for hydrophobic drug delivery. Int J Nanomedicine 13:351-366
Tang, Xiaowen; Yang, Lin; Li, Zheng et al. (2018) First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. Am J Cancer Res 8:1083-1089
Denlinger, Nathan M; Epperla, Narendranath; William, Basem M (2018) Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib. Cancer Manag Res 10:615-624

Showing the most recent 10 out of 2602 publications